title: Factors influencing seasonal patterns of relapse in anti-TNF psoriatic responders after temporary drug discontinuation.
authors.affiliation: Department of Dermatology, Reina Sofía University Hospital, Córdoba, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Ruano
authors.forename: A
authors.initials: A
authors.lastname: Velez
authors.forename: E
authors.initials: E
authors.lastname: Casas
authors.forename: A
authors.initials: A
authors.lastname: Rodriguez-Martin
authors.forename: R
authors.initials: R
authors.lastname: Salido
authors.forename: B
authors.initials: B
authors.lastname: Isla-Tejera
authors.forename: J
authors.initials: J
authors.lastname: Espejo-Alvarez
authors.forename: F
authors.initials: F
authors.lastname: Gómez
authors.forename: R
authors.initials: R
authors.lastname: Jiménez-Puya
authors.forename: J C
authors.initials: JC
authors.lastname: Moreno-Giménez
mesh_terms: D000068879:Adalimumab; D000293:Adolescent; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000503:physiopathology; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012621:Seasons; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D055815:Young Adult
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab; D000068800:Etanercept